Abstract Information

• All abstracts must be submitted electronically by the listed deadlines.
• You may submit as many abstracts as you like (but please delete incomplete abstracts that you do not plan to submit from your account).
• Nonmembers may submit abstracts without the sponsorship of a member at a higher submission rate.
• ASCB members, EMBO members, and EMBO Community members enjoy special pricing for abstract submission.
• All material must be the work of authors listed and appropriately referenced. The submitting author must provide Conflict of Interest Disclosure information and must read and agree to the ASCB Abstract License and Publishing Agreement for ALL authors.
• All abstracts will be printed and published as they appear in the Preview Step. The meeting organizers are not responsible for and will not copyedit abstract submissions. Ensure all special characters and formatting display correctly and your author block only appears once.
• All abstract submission fees are nonrefundable.
• The abstract submission fee is separate from meeting registration.

For the first deadline, August 6, there are three presentation formats to select from:

• Subgroup Talk: Your abstract will be considered for a talk in up to two Special Interest Subgroup sessions. Abstracts are sent to the Subgroup organizers and are selected at their discretion. The author information is not concealed. Talks vary in length between 10 to 15 minutes (including Q&A) depending on the format selected by the organizers.
• Microsymposium Talk (Poster Teaser): This opportunity is for trainees only. Your abstract will be considered for a poster teaser in a Microsymposium. You must also present a poster at the meeting to be considered for this opportunity. Abstracts will be scored with author information concealed by a task force. Submitters of the top 40 scoring abstracts each day will be selected to present a poster teaser prior to their scheduled poster session. Poster teasers are 5 minutes long and Q&A happens at the poster session on the same day.
• Poster Presentation: Your abstract will be considered for a poster presentation.
  • All abstracts submitted are accepted for a poster presentation if that option is selected unless they do not meet the minimum submission standards as outlined in the guidelines.
  • Abstracts are reviewed by an abstract programming task force that ensures standards are met and creates cohesive poster sessions by topic.

Talk and Poster Consideration

If you submit by the August 6 talk deadline, you can choose to be considered for up to three formats. If you select both subgroup talk and poster options, you will need to decide if you would like to give a poster if you are selected for a talk. If you want to do both, please be sure to select both the poster and talk options.

Submitting your abstract as talk only will not increase your chances of being selected for a talk.

Poster Only Consideration

If you select Poster-Only, your abstract will not be reviewed for a talk.

Abstract submission fee is separate from the meeting registration fee. Please pay the registration fee for the meeting after you submit your abstract and pay the abstract submission fee.

Content

Please be sure your abstract contains the following prior to submission:

• A sentence stating the study’s objective (unless this is provided in the title)
• A brief statement of methods, if pertinent
• A summary of the results obtained
• A statement of conclusion (it is not acceptable to state, “the results will be discussed”)

Formatting

Please follow these guidelines when formatting your abstract:

• Use a short, specific title. The title should be entered in title-style capitalization (i.e. Modeling Cytoskeletal Structures with Cytosim). Do not use a period, or place your title in quotes, use bold, or use ALL CAPS.
• DO NOT put your title or author block in the body of the abstract. 
• Capitalize initial letters of trade names.
• Please do not write given or family names, titles, or abstracts in ALL CAPS.
• Use standard abbreviations for units of measure; other abbreviations should be spelled out in full at first mention, followed by the abbreviation in parenthesis (exceptions: RNA, DNA, etc.).
• Please do not include tables, charts, or other figures.
• Be sure to proofread your work carefully before submission. A preview page will show up prior to finalizing payment. Please ensure your abstract and submission details are correct. It will be printed exactly as it appears in the abstract submission system.
• Special Characters and Formatting:
  • If copying from a Word document into the abstract submission system, be sure to select the icon on the menu bar that allows you to do this (it is the one that looks like the Microsoft Word Icon and has a green check box on it).
    • Once your text appears, please be sure to check “abstract preview” on the right to ensure all special characters and formatting convert properly.

Character Limit/Word Count

• The abstract text is limited to 2,400 characters, including spaces (~400 words). This limit includes the body of the abstract only. If your abstract exceeds this limit, you will be prompted to shorten it before being allowed to continue. There must be a minimum of 400 characters, NOT including spaces, to submit your abstract.
• The abstract title is limited to 200 characters, including spaces.
• There is no character limit for your authors or author affiliations.

Abstract Publication

All abstracts selected for presentation will be available to view online, on our virtual platform, and in the January 1, 2025 issue of Molecular Biology of the Cell.  Abstracts will be available on the Cell Bio 2023 Meeting website on or around November 22, 2024. At that time, all information is considered public.

Abstract Citation

PDF file of abstracts from the Cell Bio 2024 Meeting will be published as a supplement in the January 1, 2025, issue of Molecular Biology of the Cell.

Citation Format

Smith AB, Jones CD (2025). Abstract title. Mol. Biol. Cell 36, page # (Abstract #XXXX).

XXXX = the PRESENTATION number assigned to your abstract in early November – NOT the abstract ID number you received when you first submitted your abstract.

Page # = the page of the PDF that your abstract begins on.

View the Abstract License and Publication Agreement.

Although abstract rejection is rare, the organizers reserve the right to reject any abstract it deems inappropriate. To ensure abstract acceptance:

• Make sure your abstract includes results. Whether new findings presented in an abstract are experimental or theoretical, specific results MUST be included. The results, whether experimental or calculated, must be stated in the abstract. You are free to include your latest data in the final poster you present at the meeting, but you must include substantive results in the original abstract.
• Avoid promotion of a commercial product or service. The Abstract Program Committee tries to ensure poster sessions are not used as venues for commercial promotion. The organizers will NOT accept abstracts that promote a specific product without providing new biological insight. Statements like, “We show that X product works better than Y product” are clear indicators of promotion and will be cause for rejection. In contrast, an abstract that presents findings of interest to cell biologists, but mentions that the work was done with a proprietary and copyrighted product, and co-authors include those at the company who made the product, may be accepted.

Payment is accepted via credit card. You can pay with VISA, Mastercard, or American Express. If you are unable to pay by credit card and must pay via wire transfer, you are responsible to pay an amount that covers all fees and we must receive the wire transfer before the deadline. Therefore, please plan ahead and submit your abstract well before the deadline. 

EMBO Members and EMBO Community members should contact communications@embo.org for the discounted coupon codes if they do not have them already.

All abstract submission fees are nonrefundable. All fees must be paid prior to the listed deadlines. If you need time to send a wire transfer please submit your abstract with enough time for ASCB to receive the fees by the deadline.

Editing an Abstract

You can edit author and affiliation information until October 28 by contacting abstracts@ascb.org. If you need edits made after this time, please note that we will do our best to accommodate you, but cannot guarantee edits can be made.

You can edit the title, body, and topic selections of an abstract until the submission deadline. After these dates, please contact abstracts@ascb.org to see if we can accommodate your changes since it will have to be screened again for review.

Withdrawing an Abstract

• Login to the submission site and withdraw your abstract before the abstract deadline.
• Request abstract withdrawal before peer review via email to abstracts@ascb.org by:
  • August 8 for abstracts submitted by the August 6 deadline.
  • September 6 for abstracts submitted by the September 4 deadline.
  • October 16 for abstracts submitted by the October 15 deadline.
• Request abstract withdrawal via email to abstracts@ascb.org by October 28 so it does not appear in meeting publications. After this date, any withdrawn abstracts may still appear in Meeting materials including, but not limited to, the Online PDF of Abstracts, and the supplement to Molecular Biology of the Cell, but organizers will attempt to remove it from the mobile app.

All withdrawal requests must be in writing and must confirm that all authors have been notified and agree with the decision to withdraw. Note: Abstracts that have been submitted successfully and paid for will not be refunded, even if they are withdrawn. The only exception to this rule is if you accidentally submitted a duplicate abstract (same exact title, text, etc.). If this happens, please contact abstracts@ascb.org immediately.